EVOK · Categories · Form 4

EVOK - SEC Form 4 insider transactions

Evoke Pharma Inc. (EVOK) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EVOK

• 172d
  Large owner Nantahala Capital Management, Llc disposed of $1,629,683 worth of shares (148,153 units at $11.00) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  Chief Medical Officer Carlson Marilyn R. closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  Director Brady Todd C closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  Chief Executive Officer D'Onofrio Matthew J closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  Chief Financial Officer Kowieski Mark closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 174d
  Director Hill Malcolm R closing all direct ownership in the company (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 214d
  Large owner Klein Roger M. sold $95,885 worth of shares (9,000 units at $10.65) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 383d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 442d
  Chief Executive Officer D'Onofrio Matthew J was granted 1,000 shares, increasing direct ownership by 11% to 9,820 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 442d
  Chief Financial Officer Kowieski Mark was granted 4,500 shares, increasing direct ownership by 1,082% to 4,916 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 463d
  Chief Executive Officer D'Onofrio Matthew J was granted 6,849 shares, increasing direct ownership by 347% to 8,820 units (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 470d
  SEC Form 4 filed by Director Pyszczymuka Greg

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 495d
  Large owner Nantahala Capital Management, Llc sold $180 worth of shares (41 units at $4.39) (SEC Form 4)

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Director Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Director Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Director Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Director Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Director Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Chief Financial Officer Kowieski Mark

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 496d
  SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 595d
  SEC Form 4 filed by Director Smeal Benjamin C.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 670d
  SEC Form 4 filed by Chief Financial Officer Kowieski Mark

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 670d
  SEC Form 4 filed by Chief Medical Officer Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 670d
  SEC Form 4 filed by Chief Executive Officer D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 746d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 746d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 746d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 746d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 746d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1125d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1125d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1125d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1125d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1125d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1215d
  SEC Form 4 filed by Gonyer David A

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1215d
  SEC Form 4 filed by D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1215d
  SEC Form 4 filed by Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1503d
  SEC Form 4 filed by Widder Kenneth J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1503d
  SEC Form 4 filed by Reed Vickie S

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1503d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1503d
  SEC Form 4 filed by Garner Cam L

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1503d
  SEC Form 4 filed by Brady Todd C

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1586d
  SEC Form 4 filed by Gonyer David A

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1586d
  SEC Form 4 filed by D'Onofrio Matthew J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1586d
  SEC Form 4 filed by Carlson Marilyn R.

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1782d
  SEC Form 4 filed by WIDDER KENNETH J

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1782d
  SEC Form 4 filed by RHOADS ANN D

  4 - Evoke Pharma Inc (0001403708) (Issuer)
• 1782d
  SEC Form 4 filed by Hill Malcolm R

  4 - Evoke Pharma Inc (0001403708) (Issuer)

Other EVOK categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends